BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bio-PAT - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Bio-PAT
X-ORIGINAL-URL:https://bio-pat.org
X-WR-CALDESC:Veranstaltungen für Bio-PAT
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20231121T080000
DTEND;TZID=Europe/Paris:20231122T170000
DTSTAMP:20260427T013219
CREATED:20231120T083853Z
LAST-MODIFIED:20231120T083855Z
UID:10173-1700553600-1700672400@bio-pat.org
SUMMARY:FyoniBio at OCT DACH - Outsourcing in Clinical Trials DACH
DESCRIPTION:FyoniBio at OCT DACH – Outsourcing in Clinical Trials DACH \n\n\n\nThe OCT DACH is providing a specific platform for the clinical trials community in the DACH region to develop innovative clinical operations and outsourcing strategies. \n\n\n\nThis event will focus upon the operational challenges in clinical development found within Germany\, Austria and Switzerland. Over two days\, delegates will discuss the common challenges and trends impacting the region\, including steps for defining contractual relationships and getting the maximum from external providers\, incentivising good relationships with CROs and constructing defined deadlines. \n\n\n\nWhy Join? \n\n\n\nFocused conference for the DACH pharma market– Unlike other conferences\, the event specifically focuses on the local pharma industry in Switzerland\, Germany and Austria\, highlighting the current challenges and exciting innovations and opportunities within the marketExcellent speaker line up – Senior level speakers from leading organisations such as Roche\, AstraZeneca and Novartis along with exciting biotechs like Medac and MedigeneGreat and Diverse Sessions – OCT DACH covers a variety of topics ranging from updated EMA Guidance to Direct to Patient and Data management innovation to CRO relationshipUnbeatable Networking Opportunities –Meet and network with over 150 senior industry decision makers during our dedicated networking breaks\, round tables and interactive sessions\n\n\n\nBe sure to stop by at booth 41 of FyoniBio GmbH where Hans Baumeister\, Managing Director\, is there to enthusiastically engage with you on your new innovative projects. He will be there to discuss your needs for customized PK\, ADA and biomarker assays in your upcoming clinical development programs.FyoniBio is a member of the Bio-PAT network. \n\n\n\n\n\n\n\nAgendaRegistrationSpeakers
URL:https://bio-pat.org/event/fyonibio-at-oct-dach
LOCATION:Venue: Movenpick Zurich Hotel\, Regensdorf\, Zurich\, Schweiz
ATTACH;FMTTYPE=image/jpeg:https://bio-pat.org/wp-content/uploads/2023/11/Outsourcing-clinilcal-trials-fyonibio.jpeg
END:VEVENT
END:VCALENDAR